skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Neuropharmacology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review

Arsenault‐Mehta, Kyle ; Hochman‐Bérard, Mario ; Johnson, Alexander ; Semenova, Dar'ya ; Nguyen, Bea ; Willis, Jessie ; Mouravska, Natalia ; Joober, Ridha ; Zhand, Naista

Neuropsychopharmacology reports, 2024-03, Vol.44 (1), p.2-16 [Periódico revisado por pares]

United States: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
2
Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies
Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Advances in the Treatment of Autism Spectrum Disorder: Current and Promising Strategies

Yenkoyan, Konstantin ; Ounanian, Zadik ; Mirumyan, Margarita ; Hayrapetyan, Liana ; Zakaryan, Naira ; Sahakyan, Raisa ; Bjørklund, Geir

Current medicinal chemistry, 2024-01, Vol.31 (12), p.1485-1511 [Periódico revisado por pares]

United Arab Emirates: Bentham Science Publishers

Texto completo disponível

Citações Citado por
3
Central activation of the fatty acid sensor GPR120 suppresses microglia reactivity and alleviates sickness- and anxiety-like behaviors
Central activation of the fatty acid sensor GPR120 suppresses microglia reactivity and alleviates sickness- and anxiety-like behaviors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Central activation of the fatty acid sensor GPR120 suppresses microglia reactivity and alleviates sickness- and anxiety-like behaviors

Nakajima, Shingo ; Demers, Geneviève ; Machuca-Parra, Arturo Israel ; Pour, Zahra Dashtehei ; Bairamian, Diane ; Bouyakdan, Khalil ; Fisette, Alexandre ; Kabahizi, Anita ; Robb, Josephine ; Rodaros, Demetra ; Laurent, Cyril ; Ferreira, Guillaume ; Arbour, Nathalie ; Alquier, Thierry ; Fulton, Stephanie

Journal of neuroinflammation, 2023-12, Vol.20 (1), p.302-302, Article 302 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
4
Neuropharmacological computational analysis of longitudinal electroencephalograms in clozapine-treated patients with schizophrenia using hierarchical dynamic causal modeling
Neuropharmacological computational analysis of longitudinal electroencephalograms in clozapine-treated patients with schizophrenia using hierarchical dynamic causal modeling
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neuropharmacological computational analysis of longitudinal electroencephalograms in clozapine-treated patients with schizophrenia using hierarchical dynamic causal modeling

Eo, Jinseok ; Kang, Jiyoung ; Youn, Tak ; Park, Hae-Jeong

NeuroImage (Orlando, Fla.), 2023-07, Vol.275, p.120161-120161, Article 120161 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review
N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review

Parli, Gabrielle M. ; Gales, Mark A. ; Gales, Barry J.

Annals of Pharmacotherapy, 2023-07, Vol.57 (7), p.847-854 [Periódico revisado por pares]

Los Angeles, CA: SAGE Publications

Texto completo disponível

Citações Citado por
6
Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study
Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study

Diemen, Marcus P.J. ; Hart, Ellen P. ; Abbruscato, Anthony ; Mead, Liz ; Beelen, Ilse ; Bergheanu, Sandrin C. ; Hameeteman, Pieter W. ; Coppen, Emma ; Winder, Jessica Y. ; Moerland, Matthijs ; Kan, Hermien ; Grond, Jeroen ; Webb, Andrew ; Roos, Raymund A.C. ; Groeneveld, Geert Jan

British journal of clinical pharmacology, 2021-05, Vol.87 (5), p.2290-2302 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
7
The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice
Material Type:
Artigo 		Adicionar ao Meu Espaço

The kappa opioid receptor agonist U50,488H did not affect brain-stimulation reward while it elicited conditioned place aversion in mice

Huang, Peng ; Gentile, Taylor A ; Muschamp, John W ; Liu-Chen, Lee-Yuan

BMC research notes, 2020-08, Vol.13 (1), p.384-384, Article 384 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
8
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor
Current and Future Neuropharmacological Options for the Treatment of Essential Tremor
Material Type:
Artigo 		Adicionar ao Meu Espaço

Current and Future Neuropharmacological Options for the Treatment of Essential Tremor

Hortensia Alonso-Navarro ; Elena García-Martín ; José A.G. Agúndez ; Félix J. Jiménez-Jiménez

Current neuropharmacology, 2020-01, Vol.18 (6), p.518-537 [Periódico revisado por pares]

United Arab Emirates: Bentham Science Publishers Ltd

Texto completo disponível

Citações Citado por
9
Piperazine derivatives with central pharmacological activity used as therapeutic tools
Piperazine derivatives with central pharmacological activity used as therapeutic tools
Material Type:
Artigo 		Adicionar ao Meu Espaço

Piperazine derivatives with central pharmacological activity used as therapeutic tools

Brito, Adriane F. ; Moreira, Lorrane K. S. ; Menegatti, Ricardo ; Costa, Elson A.

Fundamental & clinical pharmacology, 2019-02, Vol.33 (1), p.13-24 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
10
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug
Material Type:
Artigo 		Adicionar ao Meu Espaço

The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug

Jalal, Baland

Psychopharmacology, 2018-11, Vol.235 (11), p.3083-3091 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (99.078)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (101.742)
  2. Anais de Congresso  (724)
  3. magazinearticle  (11)
  4. Livros  (7)
  5. Resenhas  (1)
  6. Dissertações  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1988  (13.470)
  2. 1988Até1995  (25.556)
  3. 1996Até2003  (31.468)
  4. 2004Até2012  (28.918)
  5. Após 2012  (3.079)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (15.954)
  2. Alemão  (58)
  3. Francês  (41)
  4. Chinês  (7)
  5. Português  (6)
  6. Galês  (2)
  7. Russo  (1)
  8. Espanhol  (1)
  9. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.